Wells Fargo’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$462K Sell
38,844
-75,605
-66% -$774K ﹤0.01% 4219
2025
Q4
$1.14M Buy
114,449
+35,954
+46% +$343K ﹤0.01% 3866
2025
Q3
$703K Buy
78,495
+19,084
+32% +$177K ﹤0.01% 4063
2025
Q2
$560K Buy
59,411
+3,635
+7% +$32.1K ﹤0.01% 4059
2025
Q1
$605K Buy
55,776
+1,230
+2% +$12.4K ﹤0.01% 3962
2024
Q4
$519K Buy
54,546
+14,460
+36% +$146K ﹤0.01% 4160
2024
Q3
$450K Buy
40,086
+597
+2% +$6.34K ﹤0.01% 4064
2024
Q2
$395K Buy
39,489
+7,804
+25% +$79.3K ﹤0.01% 4059
2024
Q1
$365K Buy
31,685
+4,022
+15% +$34.2K ﹤0.01% 4092
2023
Q4
$202K Buy
27,663
+1,344
+5% +$10.6K ﹤0.01% 4463
2023
Q3
$240K Sell
26,319
-41,482
-61% -$497K ﹤0.01% 4238
2023
Q2
$825K Buy
67,801
+38,020
+128% +$424K ﹤0.01% 3599
2023
Q1
$370K Buy
29,781
+14,858
+100% +$273K ﹤0.01% 4044
2022
Q4
$287K Buy
14,923
+2,227
+18% +$47.1K ﹤0.01% 3979
2022
Q3
$239K Buy
12,696
+3,645
+40% +$74.9K ﹤0.01% 4138
2022
Q2
$164K Sell
9,051
-15,924
-64% -$259K ﹤0.01% 4383
2022
Q1
$400K Sell
24,975
-17,098
-41% -$307K ﹤0.01% 4567
2021
Q4
$1.03M Sell
42,073
-2,905
-6% -$68.2K ﹤0.01% 4081
2021
Q3
$1.05M Buy
44,978
+40,055
+814% +$969K ﹤0.01% 4197
2021
Q2
$135K Sell
4,923
-170,827
-97% -$4.87M ﹤0.01% 5177
2021
Q1
$6.46M Buy
175,750
+80,759
+85% +$2.85M ﹤0.01% 2590
2020
Q4
$3.57M Sell
94,991
-148,271
-61% -$4.59M ﹤0.01% 3038
2020
Q3
$5.3M Buy
243,262
+225,879
+1,299% +$4.74M ﹤0.01% 2447
2020
Q2
$280K Buy
+17,383
New +$291K ﹤0.01% 4703

Other funds holding AHCO

Wells Fargo's AHCO Position: Q1 2026 in Review

Wells Fargo reduced its AdaptHealth (AHCO) stake by 66% in Q1 2026, selling an estimated $774K and leaving 38,844 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #4219.

Wells Fargo first reported a position in AHCO in Q2 2020 and has held it in 24 quarters since. The position peaked at $6.46M in Q1 2021. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Wells Fargo held 38,844 shares of AdaptHealth worth $462K as of Q1 2026.
  • Wells Fargo sold 75,605 AdaptHealth shares in Q1 2026, an estimated $774K.
  • AdaptHealth made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4219 holding.
  • Wells Fargo first reported a position in AdaptHealth in Q2 2020 and has held it in 24 quarters since.
  • Wells Fargo's AdaptHealth position peaked at $6.46M in Q1 2021.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.